| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |